'Nano-Keys' Bind Cell Receptors and Trigger Allergic Reactions

How cell membranes control cellular function has long been studied but with ambiguous results. However, nanotechnology now gives researchers new tools to understand the role of cell membranes in activating responses within cells.

Barbara Baird, Cornell professor of chemistry and chemical biology, reported this research today (Feb.16) at the annual meeting of the American Association for the Advancement of Science. She is the director of Cornell's Nanobiotechnology Center, which is funded by the National Science Foundation.

One day, Baird said, scientists might use these insights to develop new drug therapies for allergies and other immune responses, high cholesterol and perhaps viral infections.

By understanding a membrane's role in cell function, she explained that these nano-keys could interfere with responses via the membrane interactions, rather than just targeting proteins to block responses. This could lead to designing ligands (molecules that bind to receptors) that trigger a desired response or inhibit an allergic reaction and preventing the release of histamines and other inflammatory mediators.

In her presentation, "Design and Fabrication of Stimuli to Reveal Spatial Regulation of Cellular Signaling," she explained, "We want to understand how the receptors on cell surfaces mediate cellular responses, how cells work on a molecular level."

To study how receptors on cell membranes jump-start cellular responses, Baird and her colleagues chose to work with mast cells. They were chosen because mast cells secrete chemicals and histamines (substances released in allergic reactions that cause runny nose, watery eyes and other characteristic allergy symptoms) and they are the gatekeepers for the allergic immune response. This system can be manipulated experimentally.

Specifically, Baird works with immunoglobulin E (IgE) antibodies, which mount membrane proteins on mast cells to form receptor complexes that sense the environment and sensitize the cell to allergens, which are substances that cause an allergic reaction. Typically, two or more receptors cluster together when they bind with an antigen (allergen or foreign body), and this causes transmembrane activation of enzymes within the cell that eventually lead to the release of histamines.

Such processes begin on the nanoscale (a nanometer equals one-billionth of a meter) -- at the molecular level on the cell's surface and lead to a system-wide response. At present, very little is known about the structural changes caused by receptor clustering that allow cells to sense their outer environment and start cellular processes within the cell.

The so-called nano-keys are surfaces of silicon with a layer of polymer or a thin lipid (fatty molecules that make up cell membranes) bilayer. The surfaces, which are engineered on the micron scale (0.000001 meter; there are 25,400 microns in an inch), are arranged in patterns that contain antigens and cause IgE-receptors to cluster when the cells attach to the surface. This activates the cell's inner machinery.

Said Baird: "In this way, we can control what the cell sees. The cells are binding to the engineered surfaces and getting turned on. We can then see how the cell is organizing itself due to the stimulus."

Collaborators include: David Holowka, Cornell senior scientist in chemistry; and the research groups of Harold G. Craighead, Cornell professor of applied and engineering physics; Dan Luo, Cornell assistant professor of biological and environmental engineering; Christopher Ober, Cornell professor of materials science and engineering; Watt Webb, Cornell's Eckert Professor in Engineering; and Ulrich Wiesner, Cornell professor of materials science and engineering.

Source: Cornell University

Biochemists devise method for bypassing aluminum toxicity effects in plants
(PhysOrg.com) -- Aluminum toxicity, a global agricultural problem, halts root growth in plants, severely limiting agricultural productivity for more than half of the world's arable land.
HIV drug maraviroc effective for drug-resistant patients
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Now, maraviroc, the first of a new class of HIV drugs called CCR5 receptor antagonists, has been shown to be effective over 48 weeks for drug-resistant patients with R5 HIV-1, a variation of the virus found in more than half of HIV-infected patients.
Distinguishing between 2 birds of a feather
The bird enthusiast who chronicled the adventures of a flock of red-headed conures in his book "The Wild Parrots of Telegraph Hill" knows most of the parrots by name, yet most of us would be hard pressed to tell one bird from another. While it has been known for a long time that we can become acutely attuned to our day-to-day environment, the underlying neural mechanism has been less clear.
Potential new drug target to fight tuberculosis identified
With antibiotic resistance on the rise, tuberculosis is emerging as a bigger global health threat than ever before. But now, innovative research at Weill Cornell Medical College suggests that Mycobacterium tuberculosis has an as yet unsuspected weakness -- one that could be a prime target for drug development.
Researchers discover how antidepressants and cocaine interact with brain cell targets
In a first, scientists from Weill Cornell Medical College and Columbia University Medical Center have described the specifics of how brain cells process antidepressant drugs, cocaine and amphetamines. These novel findings could prove useful in the development of more targeted medication therapies for a host of psychiatric diseases, most notably in the area of addiction.
A new look at how genes unfold to enable their expression
(PhysOrg.com) -- Cornell researchers have uncovered surprising new information about the process by which genes are unwrapped and exposed so that they can be expressed.
Roadrunner supercomputer puts research at a new scale
Less than a week after Los Alamos National Laboratory's Roadrunner supercomputer began operating at world-record petaflop/s data-processing speeds, Los Alamos researchers are already using the computer to mimic extremely complex neurological processes.
'Nanoglassblowing' Seen as Boon to Study of Individual Molecules
While the results may not rival the artistry of glassblowers in Europe and Latin America, researchers at the National Institute of Standards and Technology and Cornell University have found beauty in a new fabrication technique called “nanoglassblowing” that creates nanoscale (billionth of a meter) fluidic devices used to isolate and study single molecules in solution—including individual DNA strands. The novel method is described in a paper posted online this week in the journal Nanotechnology.

'Nano-Keys' Bind Cell Receptors and Trigger Allergic Reactions

Related stories:

News discussion: